Mixed results from oral use of colchicine for reducing complications involved in cardiac surgery.
Hello and welcome to ashford.com you are watching an interesting video on mixed results from oral use of colchicine for reducing complications involved in cardiac surgery please read this disclaimer carefully according to a new study conducted by health economists at the university of east anglia and the center for diet and activity research in the uk walking
Or cycling to work is better for people’s mental health than driving researchers find mixed results from oral use of colchicine for reducing complications involved in cardiac surgery according to a new investigation published in jama post parrikar do demi syndrome the episode of symptoms of pericarditis including chest pain post-operative atrial fibrillation
F and post-operative pericardial pleural effusions excess fluid around the heart and lungs are all complications that can arise post cardiac surgery these these complications affect more than one-third of patients and as a result may be responsible for increased morbidity extended hospital stay lead to hospital readmissions and often a need for invasive tree in
One trial according to the paper use of colchicine assisted in the prevention of the above complications colchicine is derived from the meadow saffron autumn crocus plant colchicine is a highly toxic plant hormone that is utilized medically in the treatment of gout colchicine is derived from the meadow saffron autumn crocus plant which is plentiful and meadows
In europe and has become naturalized in parts of north america it is produced in tablets granules and ampules of sterile solution the objective of the study was to determine the effectiveness and safety of using oral colchicine to reduce complications after cardiac surgery dr. massimo amazia of maria vittori hospital torino italy and colleagues randomly assigned
360 cardiac surgery patients enrolled in 11 centers in italy to two groups the patients received either placebo or colchicine starting between 48 and 72 at two hours before surgery and continued for one month after surgery centers were encouraged to use continuous electrocardiographic ecg monitoring for at least five days after surgery patients received follow-up
Involving physical examination blood chemistry ecg echocardiography aimed at identification and assessment of pericardial effusion and thoracic cultures and at one day three days day of discharge after surgery weekly during the rehabilitation phase then it win at one month and three months at least one chest x-ray was performed during the hospital stay and then as
Clinically indicated use of colchicine significantly reduced incidence of post parrikar do demi syndrome the main outcomes of the study are as follows colchicine group post bear cardio to me occurred in 35 of 180 patients 19.4 percent post-operative i’ve occurred in 61 of 180 patients 33.9 percent post-operative pericardial pleural effusions occurred in 103 of
180 patients since 57.2 percent adverse event rates occurred in 36 of 180 patients 20.0 percent placebo group post berra cardio to me occurred in 53 of 180 patients 29.4 percent post-operative i’ve occurred in 75 of 180 patients 41.7 percent post-operative pericardial pleural effusions occurred in 106 of 180 pd patients 58.9 percent adverse event rates occurred
In 21 of 180 patients 11.7 percent the authors write in this multicenter trial perioperative administration of colchicine significantly reduced the incidence of post barrett cardio demi syndrome after cardiac surgery but did not reduce the risk of postoperative f and post-operative pericardial pleural effusions by intention-to-treat analysis they add about twenty
Percent of all patients enrolled in the trial discontinued study drug this relatively high rate may have affected the overall efficacy of the drug especially for post-operative f prevention the study released hurley online to coincide with its presentation at the european society of cardiology congress highlights that adverse event traits occurred primarily due
To increased incidence of gastrointestinal and tolerance 14.4 percent in the colchicine group and 6.7 percent in the placebo group group no serious adverse events were observed the high rate of the first effects is a reason for concern and suggests that colchicine should be considered only in well selected patients the researchers conclude references you
Transcribed from video
Mixed results from oral use of colchicine for reducing complications involved in cardiac surgery By Health • Mind • Body • Spirit